CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type ...
Sandy City, Utah, United States and 3 other locations
This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellit...
Phase 2
Salt Lake City, Utah, United States and 12 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Salt Lake City, Utah, United States of America and 24 other locations
This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insu...
Bountiful, Utah, United States and 17 other locations
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...
Phase 3
Salt Lake City, Utah, United States and 115 other locations
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
Phase 3
Salt Lake City, Utah, United States of America and 56 other locations
with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...
Phase 3
Salt Lake City, Utah, United States of America and 23 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...
Phase 3
sandy, Utah, United States of America and 78 other locations
study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...
Phase 3
Salt Lake City, Utah, United States and 183 other locations
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Salt Lake City, Utah, United States and 29 other locations
Clinical trials
Research sites
Resources
Legal